aad.org This article is for information only and does not replace medical advice
1822 GLP-1 receptor agonists exhibit several cardioprotective mechanisms that make them interesting candidates for the treatment of HF
If youre feeling unsure about how your body is responding to treatment, the experts at Nusbaum Medical Centers are here to provide the personalized guidance and clinical oversight you deserve
The prescribing indication, current dose, treatment interruption, insurance requirements, and individual side-effect history should be reviewed before switching
The mechanism of action for semaglutide and GLP-1 medications involves appetite suppression and delayed gastric emptying, leading to reduced calorie intake
This phenomenon has been corroborated by autopsy findings in PD patients, which reveal a significant presence of activated microglia in the substantia nigra and basal ganglia regions of their brains, whereas microglia in the brain tissue of healthy individuals remain in a quiescent state (He et al., 2018)